The number of products that used red yeast rice produced by Japanese drugmaker Kobayashi Pharmaceutical Co, which is being investigated for a suspected link to kidney disease and being preemptively recalled, has increased to 226 in Taiwan.
The Food and Drug Administration (FDA) on Monday last week issued an emergency recall of red yeast rice supplements from Kobayashi, citing the Osaka-based drugmaker on March 22 saying that its nutritional supplements containing red yeast rice might cause kidney problems, as it had received many reports indicating this was the case.
There were no import records of the five types of supplements that Kobayashi issued a recall on, but two Taiwanese importers of red yeast rice products made by Kobayashi had imported 56 batches between Jan. 1, 2022 and March 22, the FDA said.
Photo: EPA-EFE/JIJI PRESS
The two companies are pre-emptively recalling their products containing the red yeast rice ingredient, the agency said, adding that it has suspended applications for import inspection on Kobayashi’s red yeast rice ingredients and products.
The FDA also urged all food businesses that have used Kobayashi’s red yeast rice ingredients and products to stop using or selling them, and remove them from shelves.
They should report to the health authority, as required under the Act Governing Food Safety and Sanitation (食品安全衛生管理法), or face a fine of between NT$30,000 and NT$3 million (US$938 and US$93,780).
In Japan, Kyodo News reported that the drugmaker on Friday said that it has confirmed a fifth death possibly linked to its red yeast rice dietary supplements, and that it detected puberulic acid, a natural compound made from blue mold, in ingredients, and that the substance might have caused health problems for more than 100 people who reported falling ill after taking the supplements.
Meanwhile, FDA Deputy Director-General Lin Chin-fu (林金富) on Saturday confirmed that the agency received three reports of “unexpected reactions to food” associated with Kobayashi’s red yeast rice ingredient.
The FDA said yesterday afternoon that the number had increased to six as of 1pm yesterday.
The people reported feeling ill, but whether they have symptoms or a disease related to the supplements still needs further investigation, the agency said, adding that it would gather data for the consultative committee to assess the associations between the supplements and the unexpected reactions.
As of yesterday, the FDA’s data showed that the number of products in Taiwan that used Kobayashi’s red yeast rice ingredient and are being pre-emptively recalled has increased to 226.
A list of the products being recalled is available on the FDA’s Web site at: www.fda.gov.tw/tc/siteContent.aspx?sid=12919.
The FDA said consumers who have purchased products that used Kobayashi’s red yeast rice ingredient and have questions about it could call the FDA’s food safety hotline at 1919 or the consumers protection hotline at 1950.
People who felt ill after taking supplements that used Kobayashi’s red yeast rice ingredient could report their case to the FDA’s “unexpected reactions to health foods, nutrient foods, and capsules or tablet foods reporting platform” (http://qms.fda.gov.tw/tcbw/index.jsp) or call (02) 2321-0594, it said.
Additional reporting by CNA
ANOTHER EMERGES: The CWA yesterday said this year’s fourth storm of the typhoon season had formed in the South China Sea, but was not expected to affect Taiwan Tropical Storm Gaemi has intensified slightly as it heads toward Taiwan, where it is expected to affect the country in the coming days, the Central Weather Administration (CWA) said yesterday. As of 8am yesterday, the 120km-radius storm was 800km southeast of Oluanpi (鵝鑾鼻), Taiwan’s southernmost tip, moving at 9kph northwest, the agency said. A sea warning for Gaemi could be issued tonight at the earliest, it said, adding that the storm is projected to be closest to Taiwan on Wednesday or Thursday. Gaemi’s potential effect on Taiwan remains unclear, as that would depend on its direction, radius and intensity, forecasters said. Former Weather Forecast
As COVID-19 cases in Japan have been increasing for 10 consecutive weeks, people should get vaccinated before visiting the nation, the Centers for Disease Control (CDC) said. The centers reported 773 hospitalizations and 124 deaths related to COVID-19 in Taiwan last week. CDC Epidemic Intelligence Center Director Guo Hung-wei (郭宏偉) on Tuesday said the number of weekly COVID-19 cases reported in Japan has been increasing since mid-May and surpassed 55,000 cases from July 8 to July 14. The average number of COVID-19 patients at Japan’s healthcare facilities that week was also 1.39 times that of the week before and KP.3 is the dominant
The Chinese Communist Party’s (CCP) working group for Taiwan-related policies is likely to be upgraded to a committee-level body, a report commissioned by the Mainland Affairs Council (MAC) said. As Chinese President Xi Jinping (習近平) is increasingly likely to upgrade the CCP’s Central Leading Group for Taiwan Affairs, Taiwanese authorities should prepare by researching Xi and the CCP, the report said. At the third plenary session of the 20th Central Committee of the CCP, which ended on Thursday last week, the party set a target of 2029 for the completion of some tasks, meaning that Xi is likely preparing to
US-CHINA TRADE DISPUTE: Despite Beijing’s offer of preferential treatment, the lure of China has dimmed as Taiwanese and international investors move out Japan and the US have become the favored destinations for Taiwanese graduates as China’s attraction has waned over the years, the Ministry of Labor said. According to the ministry’s latest income and employment advisory published this month, 3,215 Taiwanese university graduates from the class of 2020 went to Japan, surpassing for the first time the 2,881 graduates who went to China. A total of 2,300 graduates from the class of 2021 went to the US, compared with the 2,262 who went to China, the document showed. The trend continued for the class of 2023, of whom 1,460 went to Japan, 1,334 went to